ZA876048B - Pharmaceutical formulation - Google Patents

Pharmaceutical formulation

Info

Publication number
ZA876048B
ZA876048B ZA876048A ZA876048A ZA876048B ZA 876048 B ZA876048 B ZA 876048B ZA 876048 A ZA876048 A ZA 876048A ZA 876048 A ZA876048 A ZA 876048A ZA 876048 B ZA876048 B ZA 876048B
Authority
ZA
South Africa
Prior art keywords
pharmaceutical formulation
formulation
pharmaceutical
Prior art date
Application number
ZA876048A
Inventor
Rochus Jonas
Jonas Rochus
Johannes Sombroek
Sombroek Johannes
Michael Klockow
Klockow Michael
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of ZA876048B publication Critical patent/ZA876048B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/556—Angiotensin converting enzyme inhibitors
ZA876048A 1986-08-14 1987-08-13 Pharmaceutical formulation ZA876048B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19863627613 DE3627613A1 (en) 1986-08-14 1986-08-14 PHARMACEUTICAL PREPARATION

Publications (1)

Publication Number Publication Date
ZA876048B true ZA876048B (en) 1988-04-27

Family

ID=6307397

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA876048A ZA876048B (en) 1986-08-14 1987-08-13 Pharmaceutical formulation

Country Status (5)

Country Link
EP (1) EP0256402A3 (en)
KR (1) KR880002521A (en)
AR (1) AR241574A1 (en)
DE (1) DE3627613A1 (en)
ZA (1) ZA876048B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6300361B1 (en) 1990-07-25 2001-10-09 Novartis Ag Stabilized pharmaceutical compositions comprising acid donors

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3818245A1 (en) * 1988-05-28 1989-12-07 Hoechst Ag COMBINATION OF ANGIOTENSIN CONVERTING ENZYME INHIBITORS WITH COLD CHANNEL MODULATORS AND THEIR USE IN MEDICINAL PRODUCTS
CA2021408A1 (en) * 1989-08-31 1991-03-01 Luana R. C. Moore Method for treating hypermotility diseases of the bowel employing an ace inhibitor and formulation for use therein
HU222489B1 (en) * 1990-07-25 2003-07-28 Novartis Ag. Stabilized pharmaceutical compositions and process for producing them

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL58849A (en) * 1978-12-11 1983-03-31 Merck & Co Inc Carboxyalkyl dipeptides and derivatives thereof,their preparation and pharmaceutical compositions containing them
DE3139064A1 (en) * 1981-10-01 1983-04-14 Merck Patent Gmbh, 6100 Darmstadt 2-Arylimidazo[4,5-c]pyridines, pharmaceutical formulations containing these, and process for their preparation

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6300361B1 (en) 1990-07-25 2001-10-09 Novartis Ag Stabilized pharmaceutical compositions comprising acid donors
US6300362B1 (en) 1990-07-25 2001-10-09 Novartis Ag (Formerly Sandoz Ltd.) Stabilized pharmaceutical compositions comprising acid donors
US6509350B2 (en) 1990-07-25 2003-01-21 Novartis Ag Stabilized pharmaceutical compositions comprising acid donors
US6790861B2 (en) 1990-07-25 2004-09-14 Novartis Ag Stabilized pharmaceutical compositions comprising acid donors

Also Published As

Publication number Publication date
AR241574A1 (en) 1992-09-30
EP0256402A3 (en) 1989-09-20
DE3627613A1 (en) 1988-02-18
KR880002521A (en) 1988-05-09
EP0256402A2 (en) 1988-02-24

Similar Documents

Publication Publication Date Title
GB8610572D0 (en) Pharmaceutical preparation
GB8613688D0 (en) Pharmaceutical composition
GB8716904D0 (en) Stable pharmaceutical preparation
GB8618847D0 (en) Pharmaceutical formulations
CS8700282A2 (en) Nicorandil-containing stable pharmaceutical
GB2187953B (en) Pharmaceutical formulation
GB8711274D0 (en) Ketoprofen pharmaceutical formulation
GB8721313D0 (en) Pharmaceutical preparation
ZA876048B (en) Pharmaceutical formulation
GB8614189D0 (en) Pharmaceutical composition
GB8712240D0 (en) Pharmaceutical formulation
GB8630419D0 (en) Pharmaceutical formulation
GB8830405D0 (en) Pharmaceutical formulation
GB8622482D0 (en) Pharmaceutical formulation
GB8630904D0 (en) Pharmaceutical formulation
GB8604244D0 (en) Pharmaceutical formulation
GB8624269D0 (en) Pharmaceutical formulation
GB8630767D0 (en) Pharmaceutical formulation
GB8630769D0 (en) Pharmaceutical formulation
GB8720073D0 (en) Pharmaceutical formulation
GB8700063D0 (en) Pharmaceutical formulation
GB8706683D0 (en) Pharmaceutical formulation
GB8706684D0 (en) Pharmaceutical formulation
GB8718131D0 (en) Pharmaceutical formulation
GB8700239D0 (en) Pharmaceutical formulation